For Class III in vitro diagnostic medical devices (IVDs) in Canada, there is no formal annual review process specifically mandated by Health Canada for the Medical Device License (MDL) itself. However, manufacturers are required to engage in ongoing compliance and monitoring activities, which may include:

1. Post-Market Surveillance

• Ongoing Monitoring: Manufacturers must implement a post-market surveillance plan to continuously monitor the safety and effectiveness of the device once it is on the market. This involves collecting data on device performance, adverse events, and user feedback.
• Adverse Event Reporting: Any serious adverse events or device-related issues must be reported to Health Canada promptly.

2. Quality Management System (QMS) Compliance

• Regular Audits: Manufacturers should conduct regular internal audits of their QMS to ensure ongoing compliance with ISO 13485 and other applicable standards. This helps maintain the quality of the device and adherence to regulatory requirements.

3. Device Modifications and Amendments

• Changes in Device Design or Use: If there are significant changes to the device (e.g., modifications in design, manufacturing process, intended use), manufacturers must notify Health Canada and may need to submit an amendment to their MDL.

4. Renewal of Licenses

• License Maintenance Fees: While the MDL does not expire, manufacturers are typically required to pay maintenance fees to keep the license active. These fees may be due annually.

5. Regulatory Updates and Compliance

• Stay Informed: Manufacturers should remain informed about any changes in regulations or guidelines from Health Canada that may affect their product. This can include changes in reporting requirements or updated standards for safety and efficacy.

Conclusion

While there is no formal annual review requirement for Class III IVD MDL registration, manufacturers are expected to engage in ongoing monitoring, maintain compliance with QMS standards, and ensure the continuous safety and effectiveness of their devices. Regular internal reviews and audits, as well as prompt reporting of any issues, are essential components of maintaining regulatory compliance and product quality.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn